Finance

Lists
CZMWY:OTCMKTS
Carl Zeiss Meditec ADR
USD 36,72
+1,46%
(+0,53) 1D
13 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CZMWY...
Open
USD 36,48
High
USD 36,75
Low
USD 36,15
Mkt. cap
2,87 mjd
Avg. vol.
3,24 k
Volume
7,35 k
52-wk high
USD 55,94
52-wk low
USD 26,65
Beta
1,42
Shares outstanding
89,44 m
No. of employees
6 k
Open
USD 36,48
High
USD 36,75
Low
USD 36,15
Mkt. cap
2,87 mjd
Avg. vol.
3,24 k
Volume
7,35 k
52-wk high
USD 55,94
52-wk low
USD 26,65
Beta
1,42
Shares outstanding
89,44 m
No. of employees
6 k
News stories
From web sources and news partners
Profile
Carl Zeiss Meditec AG is a multinational medical technology company. Headquartered in Jena, Germany, the company operates as part of the larger Carl Zeiss Group. Doing business as ZEISS Medical Technology, the company develops and manufactures solutions for ophthalmology, dentistry, oncology, neurosurgery, microsurgery, and other medical applications. Wikipedia
About Carl Zeiss Meditec ADR
CEOMarkus Weber
Employees5,8 k
Founded2002
HeadquartersJena, Thüringen, Duitsland
SectorMedical device
Websitezeiss.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
627,54 m
467,00 m
524,00 m
562,72 m
Cost of goods sold
295,75 m
239,80 m
260,62 m
260,44 m
Cost of revenue
295,75 m
239,80 m
260,62 m
260,44 m
Research and development expenses
91,78 m
75,50 m
89,30 m
78,94 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
169,64 m
152,00 m
150,59 m
162,39 m
Operating expense
261,40 m
227,50 m
237,90 m
240,02 m
Total operating expenses
557,15 m
467,30 m
498,52 m
500,46 m
Operating income
70,40 m
-300,00 k
25,48 m
62,26 m
Other non operating income
-4,02 m
-200,00 k
4,27 m
7,88 m
EBT including unusual items
67,29 m
-5,50 m
25,79 m
69,16 m
EBT excluding unusual items
62,61 m
-5,50 m
25,79 m
69,16 m
Income tax expense
13,05 m
200,00 k
6,76 m
16,40 m
Effective tax rate
19,39%
-3,64%
26,21%
23,71%
Other operating expenses
-17,00 k
-
-1,99 m
-1,31 m
Net income
51,81 m
-4,90 m
19,57 m
55,03 m
Net profit margin
8,26%
-1,05%
3,73%
9,78%
Earnings per share
-
0,03
0,45
0,54
Interest and investment income
570,00 k
1,20 m
1,28 m
2,09 m
Interest expense
-6,30 m
-6,00 m
-6,16 m
-5,93 m
Net interest expenses
-5,73 m
-4,80 m
-4,88 m
-3,84 m
Depreciation and amortization charges
-
-
-
-
EBITDA
83,01 m
12,31 m
63,70 m
74,87 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme